-
Corrigendum to “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”2022 Annals of Oncology erratum Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Peter Vogel, Andrès M.R. Cervantes, Ian Chau, Bruno Daniele, Josep Maria Llovet, Timothy Meyer, +8 more
17citations -
Corrigendum to “De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel”
Ulrike Anneliese Nitz, Oleg Gluz, Mathias Christgen, E.‐M. Grischke, Doris Augustin, Sherko Küemmel, +14 more
1citations
3 results